✨ Health Notices
4206 NEW ZEALAND GAZETTE, No. 152 21 NOVEMBER 2013
The following functions, powers and duties are vested in the limited statutory manager:
• All functions, powers and duties of the board to manage financial operations (whether statutory or otherwise).
No other functions, powers or duties are vested in the limited statutory manager.
This notice takes effect the day of publication.
Dated at Wellington this 12th day of November 2013.
KATRINA CASEY, Deputy Secretary, Sector Enablement and Support, Ministry of Education,.
go7412
Health
Health Practitioners Competence Assurance Act 2003
Reappointment to the Occupational Therapy Board
Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, the Minister of Health reappoints
Rangimahora Reddy
as a lay member of the Occupational Therapy Board for a term of office commencing on 21 November 2013 and ending on 16 September 2016.
Dated at Wellington this 11th day of November 2013.
HON TONY RYALL, Minister of Health.
go7397
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Arrow - Capecitabine
Active Ingredient: Capecitabine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturers: Intas Pharmaceuticals Limited, Gujarat, India
Intas Pharma Limited, Gujarat, India
Product: Arrow - Capecitabine
Active Ingredient: Capecitabine 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturers: Intas Pharmaceuticals Limited, Gujarat, India
Intas Pharma Limited, Gujarat, India
Product: Caverject Impulse
Active Ingredient: Alprostadil 12.8mcg equivalent to maximum dose of 10mcg after reconstitution
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Product: Caverject Impulse
Active Ingredient: Alprostadil 25.6mcg equivalent to maximum dose of 20mcg after reconstitution
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Product: Medical Carbon Dioxide
Active Ingredient: Carbon dioxide 100%
Dosage Form: Gas
New Zealand Sponsor: Air Liquide New Zealand Limited
Manufacturer: Air Liquide New Zealand Limited, Auckland, New Zealand
Dated this 14th day of November 2013.
DR JOHN CRAWSHAW, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7403
Next Page →
✨ LLM interpretation of page content
🎓
Amendment of Notice of Direction to Appoint a Limited Statutory Manager for Te Kura Kaupapa Māori o Ōtepoti
(continued from previous page)
🎓 Education, Culture & Science12 November 2013
Education, Limited Statutory Manager, Te Kura Kaupapa Māori o Ōtepoti, Board of Trustees
- Katrina Casey, Deputy Secretary, Sector Enablement and Support, Ministry of Education
🏥 Reappointment to the Occupational Therapy Board
🏥 Health & Social Welfare11 November 2013
Appointments, Occupational Therapy Board, Lay Member
- Rangimahora Reddy, Reappointed as lay member of the Occupational Therapy Board
- Hon Tony Ryall, Minister of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare14 November 2013
Medicines, Consent, Distribution, New Zealand
- Dr John Crawshaw, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2013, No 152